Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2024 - 2029)

Extra Corporeal Membrane Oxygenation (ecmo) System Market Analysis

The Extra Corporeal Membrane Oxygenation System Market size is estimated at USD 575.01 million in 2024, and is expected to reach USD 717.57 million by 2029, at a CAGR of 4.53% during the forecast period (2024-2029).

The rising incidence of cardiovascular and respiratory diseases, coupled with technological advancements in ECMO and wider adoption of ECMO systems, is projected to drive the growth of the ECMO market during the forecast period.

The rising prevalence of respiratory and cardiovascular diseases, leading to inadequate oxygen supply, has driven a surge in demand for ECMO systems. The escalating burden of respiratory and cardiovascular diseases within the population has resulted in an increased demand for ECMO systems owing to the compromised oxygen delivery capacity in these conditions. For instance, according to the 2023 statistics published by the Australian Bureau of Statistics, COPD represented a significant proportion of Australia's overall disease burden in 2023, accounting for 3.6% of the total and a staggering 50% of the respiratory disease burden. During 2021-2022, 53,000 people aged 45 years and over were hospitalized based on a principal diagnosis of COPD (500 hospitalizations per 100,000 population). Thus, the high burden of COPD is expected to increase demand for ECMO systems and is likely to contribute significantly to the growth of the critical care equipment market over the forecast period.

The increasing availability of technologically advanced ECMO systems, driven by new product launches from ECMO companies, is expected to boost market growth in the coming years. For instance, in September 2023, an ECMO life support system for pediatric patients was launched at Burjeel Medical City (BMC) in Abu Dhabi. Similarly, in June 2024, Hemovent GmbH (Hemovent), an ECMO machine manufacturer, successfully rolled out its inaugural batch of MOBYBOX for commercial use in Europe, highlighting its remarkable portability in numerous intra- and inter-hospital transfers. Notably, MOBYBOX stands as the sole ECMO system that can secure certification under the Medical Device Regulation. The product has already hit the shelves in key markets such as Germany, the Netherlands, Italy, Greece, and Israel, with plans in motion to bolster its presence in the Middle East, the United States, and China.

Therefore, the extracorporeal membrane oxygenation market is poised for growth due to the increasing burden of cardiopulmonary diseases, rising adoption of ECMO systems, and frequent product launches. However, the high costs of ECMO procedures and associated risks may hinder market expansion.

Extra Corporeal Membrane Oxygenation (ecmo) System Industry Segmentation

As per the scope of the report, extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs cannot provide an adequate amount of gas exchange or perfusion to sustain life. The technology for ECMO is primarily derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. The extracorporeal membrane oxygenation (ECMO) system market is segmented by modality, application, and geography. By modality, the market is segmented as veno-arterial (VA), veno-venous (VV), and other modalities. By application, the market is segmented into respiratory applications, cardiac applications, and extracorporeal cardiopulmonary resuscitation (CPR). By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments.